Concepedia

Bernadett Szabados

BS

Statistics

Publications

31

Citations

3K

H-Index

21

Active since

2017

Affiliations

Queen Mary University of London(Current)

The Netherlands Cancer Institute

Dana-Farber Cancer Institute

University College London

University of Calgary

Bernadett Szabados is an author at Queen Mary University of London specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2017–2024

31

Publications

31

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah et al. · Nature · 2021 · 604 citations

, , +12

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida et al. · Nature Medicine · 2019 · 571 citations · Full text

, , +13

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Tom Powles, Joaquim Bellmunt, Éva Compérat et al. · Annals of Oncology · 2021 · 525 citations · Full text

, , +14

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Bernadett Szabados, Mark Kockx, Zoe J. Assaf et al. · European Urology · 2022 · 190 citations · Full text

, , +13

ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma

Thomas Powles, Joaquim Bellmunt, Éva Compérat et al. · Annals of Oncology · 2024 · 159 citations · Full text

, , +11

1–5 of 31